Organic Letters
Letter
C. S. J. Organometallics 2011, 30, 4432. (c) Kinzel, T.; Zhang, Y.;
Buchwald, S. L. J. Am. Chem. Soc. 2010, 132, 14073. (d) Biscoe, M. R.;
Fors, B. P.; Buchwald, S. L. J. Am. Chem. Soc. 2008, 130, 6686.
(e) O’Brien, C. J.; Kantchev, E. A. B.; Valente, C.; Hadei, N.; Chass, G.
A.; Lough, A.; Hopkinson, A. C.; Organ, M. G. Chem.Eur. J. 2006, 12,
4743. (f) Bruno, N. C.; Niljianskul, N.; Buchwald, S. L. J. Org. Chem.
2014, 79, 4161−4166.
(9) (a) Jui, N. T.; Buchwald, S. L. Angew. Chem., Int. Ed. 2013, 52,
11624. (b) Yang, Y.; Oldenhuis, N. J.; Buchwald, S. L. Angew. Chem., Int.
Ed. 2013, 52, 615. (c) Bruno, N. C.; Buchwald, S. L. Org. Lett. 2013, 15,
2876. (d) Shu, W.; Buchwald, S. L. Chem. Sci. 2011, 2, 2321.
(10) (a) Friis, S. D.; Taaning, R. H.; Lindhardt, A. T.; Skrydstrup, T. J.
Am. Chem. Soc. 2011, 133, 18114. (b) Hermange, P.; Lindhardt, A. T.;
Taaning, R. H.; Bjerglund, K.; Lupp, D.; Skrydstrup, T. J. Am. Chem. Soc.
2011, 133, 6061. (c) Odell, L. R.; Russo, F.; Larhed, M. Synlett. 2012,
685. (d) Morimoto, T.; Kakiuchi, K. Angew. Chem., Int. Ed. 2004, 43,
5580.
shown using tritylamine as the nucleophile. Due to the generality
of the method and its ease of use, it should see wide utilization in
both academic and industrial, particularly pharmaceutical,
settings.
ASSOCIATED CONTENT
* Supporting Information
■
S
Experimental procedures and spectroscopic data. This material is
AUTHOR INFORMATION
Corresponding Authors
■
(11) (a) Kranenburg, M.; van der Burgt, Y. E. M.; Kamer, P. C. J.; van
Leeuwen, P. W. N. M.; Goubitz, K.; Fraanje, J. Organometallics 1995, 14,
3081. (b) van Leeuwen, P. W. N. M.; Kamer, P. C. J.; Reek, J. N. H.;
Dierkes, P. Chem. Rev. 2000, 100, 2741. (c) Other XantPhos-like ligands
including HomoXantPhos and DBFphos provided only poorer yield.
(12) (a) This is noteworthy because the α-ketoamides are generally
accessed via low temperature double carbonylation of the corresponding
aryl iodide. Unfortunately, this reaction could not be optimized to
produce 3b in a synthetically useful yield. (b) Iizuka, M.; Kondo, Y.
Chem. Commun. 2006, 1739. (c) Nielsen, D. U.; Neumann, K.; Taaning,
R. H.; Lindhardt, A. T.; Modvig, A.; Skrydstrup, T. J. Org. Chem. 2012,
77, 6155.
(13) Attempts to couple the 2-bromopyrimidine cleanly afforded a 1:3
mixture of the desired amide and 4-(pyrimidin-2-yl)morpholine, arising
from SNAr substitution. Product distribution was determined by analysis
of the crude 1H NMR spectrum.
(14) Costantino, L.; Barlocco, D. Curr. Med. Chem. 2006, 13, 65.
(15) (a) Giandinoto, S.; Mbagwu, G. O.; Robinson, T. A.; Ferguson,
Notes
The authors declare the following competing financial
interest(s): MIT holds or has filed patents on some of the
ligands and precatalysts used in this work, for which S.L.B.
receives royalty payments. T.S. is a co-owner of SyTracks a/s.
ACKNOWLEDGMENTS
■
Research reported in this publication was supported by the
National Institutes of Health under award number GM46059.
The content is solely the responsibility of the authors and does
not necessarily represent the official views of the National
Institutes of Health. We also thank the Danish National Research
Foundation (Grant number DNRF59), the Villum Foundation,
the Danish Council for Independent Research: Technology and
Production Sciences for generous financial support of this work.
C.; Nunez, J. J. Heterocycl. Chem. 1996, 33, 1839. (b) Schnurch, M.;
Waldner, B.; Hilber, K.; Mihovilovic, M. D. Bioorg. Med. Chem. Lett.
2011, 21, 2149.
(16) Reddy, D. R.; Iqbal, M. A.; Hudkins, R. L.; Messina-McLaughlin,
P. A.; Mallamo, J. P. Tetrahedron Lett. 2002, 43, 8063.
(17) (a) Friis, S. D.; Andersen, T. L.; Skrydstrup, T. Org. Lett. 2013, 15,
1378. (b) Korsager, S.; Nielsen, D. U.; Taaning, R. H.; Skrydstrup, T.
Angew. Chem., Int. Ed. 2013, 52, 9763.
̈
REFERENCES
■
(1) (a) Roughley, S. D.; Jordan, A. M. J. Med. Chem. 2011, 54, 3451.
(b) Baumann, M.; Baxendale, I. R. Beilstein J. Org. Chem. 2013, 9, 2265.
(c) Carey, J. S.; Laffan, D.; Thomson, C.; Williams, M. T. Org. Biomol.
Chem. 2006, 4, 2337.
(2) (a) John, A. Joule, K. M. Heterocyclic Chemistry, 5th ed.; Wiley: New
York, 2010. (b) Dufert, M. A.; Billingsley, K. L.; Buchwald, S. L. J. Am.
̈
Chem. Soc. 2013, 135, 12877. (c) Hooper, M. W.; Hartwig, J. F.
Organometallics. 2003, 22, 3394.
(3) (a) Su, M.; Buchwald, S. L. Angew. Chem., Int. Ed. 2012, 51, 4710.
(b) Kumar, K.; Zapf, A.; Michalik, D.; Tillack, A.; Heinrich, T.; Bottcher,
̈
H.; Arlt, M.; Beller, M. Org. Lett. 2003, 6, 7. (c) Shen, Q.; Ogata, T.;
Hartwig, J. F. J. Am. Chem. Soc. 2008, 130, 6586.
(4) (a) Ivanov, A. S.; Zhalnina, A. A.; Shishkov, S. V. Tetrahedron 2009,
65, 7105. (b) Marsham, P. R.; Hughes, L. R.; Jackman, A. L.; Hayter, A.
J.; Oldfield, J.; Wardleworth, J. M.; Bishop, J. A. M.; O’Connor, B. M.;
Calvert, A. H. J. Med. Chem. 1991, 34, 1594. (c) Hu, B.; Song, Q.; Xu, Y.
Org. Process Res. Dev. 2012, 16, 1552.
(5) (a) Brennfuhrer, A.; Neumann, H.; Beller, M. Angew. Chem., Int. Ed.
̈
2009, 48, 4114. (b) Alsabeh, P. G.; Stradiotto, M.; Neumann, H.; Beller,
M. Adv. Synth. Catal. 2012, 354, 3065. (c) Nordeman, P.; Odell, L. R.;
Larhed, M. J. Org. Chem. 2012, 77, 11393. (d) Martinelli, J. R.; Watson,
D. A.; Freckmann, D. M. M.; Barder, T. E.; Buchwald, S. L. J. Org. Chem.
2008, 73, 7102. (e) Martinelli, J. R.; Clark, T. P.; Watson, D. A.;
Munday, R. H.; Buchwald, S. L. Angew. Chem., Int. Ed. 2007, 46, 8460.
(f) Wu, X.-F.; Neumann, H.; Beller, M. Chem. Rev. 2013, 113, 1.
(g) Grigg, R.; Mutton, S. P. Tetrahedron. 2010, 66, 5515. (h) Beller, M.;
Wu, X.-F. Transition Metal Catalyzed Carbonylation Reactions: Carbon-
ylative Activation of C-X Bonds; Springer: New York, 2013.
(6) (a) Begouin, A.; Queiroz, M. J. R. P. Eur. J. Org. Chem. 2009, 2820.
(b) Letavic, M. A.; Ly, K. S. Tetrahedron Lett. 2007, 48, 2339.
(7) Quesnel, J. S.; Arndtsen, B. A. J. Am. Chem. Soc. 2013, 135, 16841.
(8) (a) Bruno, N. C.; Tudge, M. T.; Buchwald, S. L. Chem. Sci. 2013, 4,
916. (b) Chartoire, A.; Lesieur, M.; Slawin, A. M. Z.; Nolan, S. P.; Cazin,
4299
dx.doi.org/10.1021/ol502014b | Org. Lett. 2014, 16, 4296−4299